Skip to Content
Return to Search

EGVI endoglucanase and nucleic acids encoding the same

United States Patent Application

View the Complete Application at the US Patent & Trademark Office
National Renewable Energy Laboratory - Visit the NREL Technology Transfer Website
The present invention provides a novel endoglucanase nucleic acid sequence, designated egl6, and the corresponding EGVI amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVI, recombinant EGVI proteins and methods for producing the same.
Dunn-Coleman, Nigel (Los Gatos, CA), Goedegebuur, Frits (Vlaardingen, NL), Ward, Michael (San Francisco, CA), Yao, Jian (Sunnyvale, CA)
11/ 329,714
January 10, 2006
GOVERNMENT SUPPORT [0001] Portions of this work were funded by Subcontract No. ZCO-30017-01 with the National Renewable Energy Laboratory under Prime Contract No. DE-AC36-99GO10337 with the U.S. Department of Energy. Accordingly, the United States Government may have certain rights in this invention.